In recent years, the medical dispensing skin care market has experienced remarkable evolution, defying economic uncertainties and registering gains across all key markets analyzed by Kline+ Company. The global market has been growing at a staggering 15% since 2020, with North America remaining the largest and fastest-growing market, followed by Latin America.
The rise of integrated skin care solutions contribute to the market’s dynamics, offering comprehensive approaches to efficiently and effectively address various skin concerns. From advanced imaging techniques for precise skin analysis to sophisticated delivery systems for topical treatments, skin care professionals now have access to a wide array of tools to meet the demands of today’s consumers. One example is Mesoestetic’ Genesis, an optimized and updated version of its multi-technology device.
Genesis by Mesoestetic
The growing interest from younger generations has spurred the demand for cost-effective treatment alternatives, driving advancements in clinic technologies. Particularly notable is the increased interest in laser treatments, especially those addressing multiple skin care concerns simultaneously in a single session.
One noteworthy trend observed across all key markets is the surge in demand for gentle yet effective anti-aging solutions, spearheaded by leading brands. Prominent examples include SkinCeuticals‘ A.G.E. Interrupter Advanced and iS Clinical‘s Retinol+ Emulsion 0.3. Additionally, the market also witnessed a shift toward incorporating plant-based ingredients such as squalene, exemplified by Image Skincare for its Biome+ range, among other brands.
-
- A.G.E. Interrupter Advanced by SkinCeuticals
-
- Retinol+ Emulsion 0.3 by iS Clinical
-
- Biome+ range by Image Skincare
Within the competitive landscape, key industry players such as SkinCeuticals, ZO Skin Health, and Obagi continue to fortify their global presence through strategic distribution expansions, innovative product launches, and refined marketing strategies. Concurrently, emerging contenders such as Alastin are rapidly expanding their footprint, targeting important dispensing markets such as Mexico, the United Kingdom, and Australia. In this dynamic landscape, local brands such as AlumierMD in Canada and DMK in Australia are also seizing opportunities, adding to the vibrant competition within their respective markets.
As consumer preferences evolve and competition heats up, marketers seeking growth or expansion in the medical dispensing space should focus on:
- Positioning brands as authorities in skin care by providing valuable educational content about dermatological principles, treatment options, and ingredient science
- Leveraging data-driven insights, advanced diagnostics, and consultations to create personalized treatment plans
- Investing in research and development to introduce new formulations, delivery systems, and treatment options
Kline + Company’s extensive coverage of the medical-dispensing skin care market includes a global screening assessment of 65 markets, an in-depth review of highly dynamic markets of Australia, Canada, China, France, Mexico, and the United Kingdom, and a mid-year 2024 update on the United States, the leading and fastest-growing market globally. Whether you are looking to assess competitors, expand into new markets, understand the regulatory landscape, or stay ahead of key trends and new developments, these resources empower you to make informed decisions and drive success in the dynamic medical-dispensing skin care industry. To learn more, speak to an industry expert today.
Want regular beauty industry updates, expert analysis, insider tips, and webinar invites in your inbox? Click here to sign up for the Kline newsletter.
